Trial Profile
Phase I/II Study to Assess the Safety and Efficacy of Low Doses of Beta LT in Patients With Myeloma.
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Beta alethine (Primary)
- Indications Myeloma; Smoldering multiple myeloma
- Focus Therapeutic Use
- 21 May 2021 Results presented at the 112th Annual Meeting of the American Association for Cancer Research
- 01 Oct 2005 New trial record.